Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipid-mediated intracellular delivery of recombinant bioPROTACs for the rapid degradation of undruggable proteins
Alexander Chan, Rebecca M. Haley, Mohd Altaf Najar, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13

Showing 13 citing articles:

Nano-Encapsulation and Conjugation Applied in the Development of Lipid Nanoparticles Delivering Nucleic Acid Materials to Enable Gene Therapies
Linh Đinh, Lanesa Mahon, Bingfang Yan
Applied Nano (2024) Vol. 5, Iss. 3, pp. 143-161
Open Access | Times Cited: 7
Unlocking the Potential of RGD-Conjugated Gold Nanoparticles: A New Frontier in Targeted Cancer Therapy, Imaging, and Metastasis Inhibition
Hossein Javid, Mahsa Akbari Oryani, Nastaran Rezagholinejad, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 42, pp. 10786-10817
Closed Access | Times Cited: 5
Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
Lisha Ou, Mekedlawit Setegne, Jeandele Elliot, et al.
Chemical Reviews (2025)
Closed Access
Structural, Biological, and Biomedical Implications of mRNA Interactions with the Master Regulator HuR
Miriam Marty Clark, Andrew Farinha, Alan Morrison, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Closed Access
Engineering Cell-Specific Protein Delivery Vehicles for Erythroid Lineage Cells
Mekedlawit Setegne, Aidan T. Cabral, Anushri Tiwari, et al.
ACS Bio & Med Chem Au (2025)
Open Access
Recent advances in targeted degradation in the RAS pathway
Zhiming Ge, Zisheng Fan, Wei He, et al.
Future Medicinal Chemistry (2025), pp. 1-16
Closed Access
TogoPhosTAC: A Ready-To-Go and Adaptable Targeted Protein Dephosphorylation System
Po‐Han Chen, Yu-Yu Chen, Dong-Ting Ke, et al.
Research Square (Research Square) (2025)
Closed Access
Designed peptide binders and nanobodies as PROTAC starting points for targeted degradation of PCNA and BCL6
Shuai Zhao, Jingwen Luo, Pingping Xu, et al.
International Journal of Biological Macromolecules (2025), pp. 142667-142667
Closed Access
Programmable protein stabilization with language model-derived peptide guides
Lauren Hong, Tianzheng Ye, Tian Wang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes
Janarthanan Venkatesan, Dhanashree Murugan, Kalaiarasu Lakshminarayanan, et al.
Pharmacology & Therapeutics (2024) Vol. 263, pp. 108725-108725
Closed Access | Times Cited: 2
PROTAC delivery in tumor immunotherapy: Where are we and where are we going?
Yiyang Li, Yike Wu, Shugeng Gao, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 116-144
Closed Access | Times Cited: 1
Programmable protein degraders enable selective knockdown of pathogenic β-catenin subpopulationsin vitroandin vivo
Tianzheng Ye, Azmain Alamgir, Cara M. Robertus, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Better, Faster, Stronger: Accelerating mRNA‐Based Immunotherapies With Nanocarriers
Henrique Carvalho, Tiago A. S. Fidalgo, Rita C. Acúrcio, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Open Access
DARPins as a novel tool to detect and degrade p73
Philipp Münick, Jan M. Zielinski, Alexander Strubel, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 12
Open Access
Page 1

Scroll to top